Chengdu Tetrahedral Drug Research

Chengdu Tetrahedral Drug Research is a biotechnology company and contract research organization (CRO) specializing in DNA-encoded library (DEL) technology for drug discovery. Based in Chengdu, China, the company provides advanced services to pharmaceutical and biotech partners, leveraging a proprietary platform to design, synthesize, and screen massive chemical libraries containing billions of DNA-tagged small molecules. This technology enables the rapid identification of novel chemical hits against a wide variety of therapeutic targets, significantly accelerating the early drug discovery timeline. Beyond screening, Tetrahedral offers expertise in medicinal chemistry, lead optimization, and chemical biology to support the transition from hit to lead. The company is led by experienced scientists with backgrounds in global pharmaceutical organizations, focusing on high-quality data and innovative chemical space exploration.